Universal Ibogaine Inc. (IBOGF)
Universal Ibogaine Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $31,286. On trailing twelve-month figures it carries a trailing P/E of -0.50, a net margin of -88.0%. Its beta of 4.38 implies it has historically moved more than the broad market.
Universal Ibogaine Inc. is a life sciences enterprise that focuses on creating, obtaining, and managing addiction treatment centers throughout Canada. The company is also actively involved in scheduled clinical trials, researching the efficacy of ibogaine as a treatment for addiction. Its operations are directed from its head office in Calgary, Canada.
Universal Ibogaine Inc. is most often compared with the following Healthcare names: